Christina Cool

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Childhood Cancer

Top Venues

Expert review of pharmacoeconomics & outcomes research

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Bullano, Christina Cool, Bob G Schultz, Sneha Durgapal, Naomi C Sacks, Yanmei Liu, Rebecca Kee, Katharine Batt
Evaluating the financial impact of utilizing recombinant porcine factor VIII or recombinant FVIIa for patients with acquired hemophilia A. Expert review of pharmacoeconomics & outcomes research (2023)
Michael Bullano, Christina Cool, Bob G Schultz, Sneha Durgapal, Naomi C Sacks, Yanmei Liu, Rebecca Kee, Katharine Batt
Evaluating the financial impact of utilizing recombinant porcine factor VIII or recombinant FVIIa for patients with acquired hemophilia A. Expert review of pharmacoeconomics & outcomes research 23 (2) (2023)
Michael Bullano, Christina Cool, Bob G Schultz, Sneha Durgapal, Naomi C Sacks, Yanmei Liu, Rebecca Kee, Katharine Batt
Evaluating the financial impact of utilizing recombinant porcine factor VIII or recombinant FVIIa for patients with acquired hemophilia A. Expert review of pharmacoeconomics & outcomes research 23 (2) (2023)
Michael Bullano, Christina Cool, Bob G Schultz, Sneha Durgapal, Naomi C Sacks, Yanmei Liu, Rebecca Kee, Katharine Batt
Evaluating the financial impact of utilizing recombinant porcine factor VIII or recombinant FVIIa for patients with acquired hemophilia A. Expert review of pharmacoeconomics & outcomes research 23 (2) (2023)
Michael Bullano, Christina Cool, Bob G Schultz, Sneha Durgapal, Naomi C Sacks, Yanmei Liu, Rebecca Kee, Katharine Batt
Evaluating the financial impact of utilizing recombinant porcine factor VIII or recombinant FVIIa for patients with acquired hemophilia A. Expert review of pharmacoeconomics & outcomes research (2022)